Beijing to add 17 cancer drugs to insurance
A pharmacist takes drugs at a hospital in Beijing. [Photo/VCG]
Starting from Nov 15, Beijing will list 17 new cancer drugs in its public medical insurance system, the Beijing Municipal Human Resources and Social Security Bureau announced on Oct 31.
By then, 35 cancer drugs in total will be included in the capital's medical insurance, further reducing the burden of residents' medicine costs when fighting against cancer.
The period of validity of insurance payment standards for those 17 cancer drugs is from the middle of next month to Nov 30, 2020. From then, the government will adjust payment standards accordingly.
- China Medical Expert Team arrives in DR Congo to aid battle against Ebola, leveraging expertise and China's experience in epidemic control: team members
- China to send medical expert team to DR Congo for Ebola control
- Senior WHO official highlights China's role in tackling global health challenges
- Focus on the World Health Assembly | Healthy China, not just China
- China builds robust nursing workforce amid healthcare push
- NHC minister meets with president of Merieux Foundation